TY - JOUR
T1 - Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis
AU - Maiers, Jessica L.
AU - Malhi, Harmeet
N1 - Funding Information:
This work was supported in part by NIH grants DK111378 (H. M.), DK112915 (J. L. M), and by Gilead Sciences Research Scholars Program in Liver Disease (H. M.).
Publisher Copyright:
© 2019 by Thieme Medical Publishers, Inc.
PY - 2019
Y1 - 2019
N2 - Endoplasmic reticulum (ER) stress is a major contributor to liver disease and hepatic fibrosis, but the role it plays varies depending on the cause and progression of the disease. Furthermore, ER stress plays a distinct role in hepatocytes versus hepatic stellate cells (HSCs), which adds to the complexity of understanding ER stress and its downstream signaling through the unfolded protein response (UPR) in liver disease. Here, the authors focus on the current literature of ER stress in nonalcoholic and alcoholic fatty liver diseases, how ER stress impacts hepatocyte injury, and the role of ER stress in HSC activation and hepatic fibrosis. This review provides insight into the complex signaling and regulation of the UPR, parallels and distinctions between different liver diseases, and how ER stress may be targeted as an antisteatotic or antifibrotic therapy to limit the progression of liver disease.
AB - Endoplasmic reticulum (ER) stress is a major contributor to liver disease and hepatic fibrosis, but the role it plays varies depending on the cause and progression of the disease. Furthermore, ER stress plays a distinct role in hepatocytes versus hepatic stellate cells (HSCs), which adds to the complexity of understanding ER stress and its downstream signaling through the unfolded protein response (UPR) in liver disease. Here, the authors focus on the current literature of ER stress in nonalcoholic and alcoholic fatty liver diseases, how ER stress impacts hepatocyte injury, and the role of ER stress in HSC activation and hepatic fibrosis. This review provides insight into the complex signaling and regulation of the UPR, parallels and distinctions between different liver diseases, and how ER stress may be targeted as an antisteatotic or antifibrotic therapy to limit the progression of liver disease.
KW - Unfolded protein response
KW - hepatic stellate cells
KW - nonalcoholic fatty liver disease
KW - steatosis
UR - http://www.scopus.com/inward/record.url?scp=85065196771&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065196771&partnerID=8YFLogxK
U2 - 10.1055/s-0039-1681032
DO - 10.1055/s-0039-1681032
M3 - Article
C2 - 30912096
AN - SCOPUS:85065196771
SN - 0272-8087
VL - 39
SP - 235
EP - 248
JO - Seminars in Liver Disease
JF - Seminars in Liver Disease
IS - 2
ER -